124 results
DEFA14A
FRTX
Fresh Tracks Therapeutics, Inc.
13 Nov 23
Additional proxy soliciting materials
8:58am
of innovative and ground-breaking prescription therapeutics. Unfortunately, after conducting an extensive, months-long process to explore and evaluate potential
DEFA14A
nxemtiaq
13 Nov 23
Additional proxy soliciting materials
8:48am
8-K
EX-99.1
1ireyw 41
13 Nov 23
Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:33am
8-K
EX-99.1
f8tedl 9oyjv46syjn
11 Aug 23
Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
pgara6gufa ijjjda22
21 Jul 23
Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix
8:02am
8-K
EX-99.1
waizxsezn zrp0sl549
10 May 23
Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:04pm
8-K
EX-99.1
pvdt0p70
30 Mar 23
Fresh Tracks Therapeutics Reports Fourth Quarter and Full Year 2022
4:03pm
8-K
EX-99.1
5m29ghkyf86zmms4
10 Nov 22
Fresh Tracks Therapeutics Reports Third Quarter 2022
4:10pm